Brilliant Pharmaceuticals Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Private

  • Employees
  • 3,322

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 4

Brilliant Pharmaceuticals General Information

Description

Researcher and developer of new drugs, generic drugs, and traditional Chinese medicines (TCM). The company's products include anti-infectives and drugs targeting multiple biological systems including cardiovascular, respiratory, urinary, and more aimed to help regulate patients' bodies, helping them live a healthy and energetic life.

Contact Information

Website
www.btyy.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No.1166, Konggang 4th Road
  • Southwest Airport Economic Development Zone, Shuangliu District
  • Chengdu, Sichuan
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • No.1166, Konggang 4th Road
  • Southwest Airport Economic Development Zone, Shuangliu District
  • Chengdu, Sichuan
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brilliant Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 13-Jan-2022 Cancelled Generating Revenue
6. Secondary Transaction - Private 27-Jun-2019 Completed Generating Revenue
5. Secondary Transaction - Private 29-Mar-2019 Completed Generating Revenue
4. Later Stage VC 09-Jan-2019 Completed Generating Revenue
3. Secondary Transaction - Private 05-Dec-2018 Completed Generating Revenue
2. Later Stage VC 20-Sep-2018 $7.3M $7.3M Completed Generating Revenue
1. Later Stage VC Completed Generating Revenue
To view Brilliant Pharmaceuticals’s complete valuation and funding history, request access »

Brilliant Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Brilliant Pharmaceuticals’s complete cap table history, request access »

Brilliant Pharmaceuticals Patents

Brilliant Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026233290-A1 Rnai composition and use thereof Pending 07-May-2025
WO-2026228529-A1 New crystal form of compound containing bis(azanylylidene) sulfonyl structure Pending 27-Apr-2025
WO-2026219263-A1 Modified double-stranded oligonucleotide and use thereof Pending 15-Apr-2025
WO-2026158295-A1 Hbv-targeting small nucleic acid Pending 21-Jan-2025
WO-2026139009-A1 Rnai composition and use thereof Pending 27-Dec-2024
To view Brilliant Pharmaceuticals’s complete patent history, request access »

Brilliant Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brilliant Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Juxin Development Equity Investment Fund Management PE/Buyout Minority
Jundu Investment Growth/Expansion Minority
Beijing Guosheng Asset Management Growth/Expansion Minority
Daoyuan Capital Venture Capital Minority
To view Brilliant Pharmaceuticals’s complete investors history, request access »

Brilliant Pharmaceuticals Acquisitions (1)

Brilliant Pharmaceuticals’s most recent deal was a Merger/Acquisition with Sanfengyou. The deal was made on 26-Jul-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sanfengyou 26-Jul-2022 Merger/Acquisition Pharmaceuticals
To view Brilliant Pharmaceuticals’s complete acquisitions history, request access »

Brilliant Pharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sanfengyou Haikou, China 2005

Brilliant Pharmaceuticals FAQs

  • When was Brilliant Pharmaceuticals founded?

    Brilliant Pharmaceuticals was founded in 1995.

  • Where is Brilliant Pharmaceuticals headquartered?

    Brilliant Pharmaceuticals is headquartered in Chengdu, China.

  • What is the size of Brilliant Pharmaceuticals?

    Brilliant Pharmaceuticals has 3,322 total employees.

  • What industry is Brilliant Pharmaceuticals in?

    Brilliant Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Brilliant Pharmaceuticals a private or public company?

    Brilliant Pharmaceuticals is a Private company.

  • What is Brilliant Pharmaceuticals’s current revenue?

    The current revenue for Brilliant Pharmaceuticals is .

  • How much funding has Brilliant Pharmaceuticals raised over time?

    Brilliant Pharmaceuticals has raised $7.3M.

  • Who are Brilliant Pharmaceuticals’s investors?

    Juxin Development Equity Investment Fund Management, Jundu Investment, Beijing Guosheng Asset Management, and Daoyuan Capital have invested in Brilliant Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process